|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,535.00 JPY | +1.17% |
|
+3.12% | +24.43% |
| 01-30 | Shionogi & Co.'s Nine-Month Profit Jumps 18% | MT |
| 01-29 | Shionogi & Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2025 | CI |
Business description: Shionogi & Co., Ltd.
Number of employees: 4,955
Sales by Activity: Shionogi & Co., Ltd.
| Fiscal Period: March | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) |
|---|---|---|---|---|---|
Prescription Drugs | 297B | 335B | 427B | 435B | 438B |
Geographical breakdown of sales: Shionogi & Co., Ltd.
| Fiscal Period: March | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) |
|---|---|---|---|---|---|
United Kingdom | 145B | 184B | 175B | 201B | 246B |
Japan | 119B | 114B | 208B | 155B | 130B |
United States of America | 8.95B | 14.32B | 16.25B | 18.03B | 23.44B |
Europe (Excl. UK) | 9.06B | 7.43B | 10.28B | 17.7B | 20.16B |
Others | 15.11B | 15.59B | 17.67B | 17.77B | 19.15B |
North America (Excl. US) | 12M | 8M | 6M | 5M | - |
Executive Committee: Shionogi & Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 66 | 2022-06-30 |
John Keller
CTO | Chief Tech/Sci/R&D Officer | 61 | 2022-06-30 |
Kenji Matsuo
DFI | Director of Finance/CFO | - | - |
Takeshi Shiota
PRN | Corporate Officer/Principal | - | 2014-12-31 |
| Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Shionogi & Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 75 | 2019-05-31 |
Isao Teshirogi
CHM | Chairman | 66 | 2022-06-30 |
Shuichi Okuhara
BRD | Director/Board Member | 57 | 2025-05-31 |
Noriyuki Kishida
BRD | Director/Board Member | 65 | 2025-05-31 |
Kohji Hanasaki
BRD | Director/Board Member | 64 | 2025-05-31 |
Takaoki Fujiwara
BRD | Director/Board Member | 74 | 2023-05-31 |
Keiichi Ando
BRD | Director/Board Member | 74 | 2016-05-31 |
John Keller
BRD | Director/Board Member | 61 | 2025-04-30 |
Fumi Takatsuki
BRD | Director/Board Member | 50 | 2020-05-31 |
Kyoko Hirose
BRD | Director/Board Member | 66 | 2025-05-31 |
Holdings: Shionogi & Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
SHIONOGI & CO., LTD. 3.33% | 29,655,900 | 3.33% | 610 M $ |
| 3,452,430 | 0.09% | 122 M $ | |
TOHO HOLDINGS CO., LTD. 4.79% | 3,500,000 | 4.79% | 105 M $ |
| 914,000 | 1.96% | 27 M $ | |
| 1,315,663 | 0.61% | 24 M $ | |
STEMRIM 7.42% | 4,650,000 | 7.42% | 9 M $ |
KANEKA CORPORATION 0.4% | 266,600 | 0.4% | 8 M $ |
| 344,095 | 0.07% | 5 M $ | |
| 519,058 | 1% | 5 M $ | |
| 386,898 | 1.59% | 2 M $ |
Company details: Shionogi & Co., Ltd.
Other Pharmaceuticals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.17% | +3.12% | +68.09% | +69.25% | 19.39B | |
| -0.96% | -8.30% | +17.37% | +194.16% | 909B | |
| +1.05% | +2.73% | +54.27% | +48.54% | 580B | |
| -0.70% | +1.74% | +15.15% | +45.27% | 390B | |
| +0.46% | -0.28% | +22.63% | +28.12% | 370B | |
| -0.36% | +2.72% | +25.28% | +52.35% | 305B | |
| +0.87% | +6.81% | +26.52% | +30.73% | 314B | |
| +1.84% | +0.83% | +37.87% | +9.89% | 296B | |
| +0.38% | +9.66% | -47.46% | -38.08% | 216B | |
| +0.53% | +0.10% | +23.57% | +51.17% | 197B | |
| Average | +0.38% | +1.21% | +24.33% | +49.14% | 359.68B | |
| Weighted average by Cap. | +0.36% | -0.53% | +23.49% | +73.52% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4507 Stock
- Company Shionogi & Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition